Adding genetic risk score to family history identifies twice as many high-risk men for prostate cancer: Results from the prostate cancer prevention trial

Impact of Family History on Prostate Cancer Mortality in White Men Undergoing Prostate Specific Antigen Based Screening

(2015) Michael A. Liss et al.   JOURNAL OF UROLOGY

A Large Multiethnic Genome-Wide Association Study of Prostate Cancer Identifies Novel Risk Variants and Substantial Ethnic Differences

(2015) T. J. Hoffmann et al.   Cancer Discovery

A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer

(2014) Ali Amin Al Olama et al.   NATURE GENETICS

Screening for Prostate Cancer: A Review of the Evidence for the U.S. Preventive Services Task Force

(2013) Roger Chou et al.   ANNALS OF INTERNAL MEDICINE

Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement

(2013) Virginia A. Moyer   ANNALS OF INTERNAL MEDICINE

Prostate cancer risk-associated genetic markers and their potential clinical utility

(2013) Jianfeng Xu et al.   ASIAN JOURNAL OF ANDROLOGY

Early Detection of Prostate Cancer: AUA Guideline

(2013) H. Ballentine Carter et al.   JOURNAL OF UROLOGY

Long-Term Survival of Participants in the Prostate Cancer Prevention Trial

(2013) Ian M. Thompson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Common Genetic Variants in Prostate Cancer Risk Prediction--Results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3)

(2012) S. Lindstrom et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Potential Impact of Adding Genetic Markers to Clinical Parameters in Predicting Prostate Biopsy Outcomes in Men Following an Initial Negative Biopsy: Findings from the REDUCE Trial

(2012) A. Karim Kader et al.   EUROPEAN UROLOGY

Genetic Score Is an Objective and Better Measurement of Inherited Risk of Prostate Cancer than Family History

(2012) Jielin Sun et al.   EUROPEAN UROLOGY

Prostate Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality Results after 13 Years of Follow-up

(2012) G. L. Andriole et al.   JNCI-Journal of the National Cancer Institute

Prostate-Cancer Mortality at 11 Years of Follow-up

(2012) Fritz H. Schröder et al.   NEW ENGLAND JOURNAL OF MEDICINE

Reproducibility, Performance, and Clinical Utility of a Genetic Risk Prediction Model for Prostate Cancer in Japanese

(2012) Shusuke Akamatsu et al.   PLoS One

Polygenic Risk Score Improves Prostate Cancer Risk Prediction: Results from the Stockholm-1 Cohort Study

(2011) Markus Aly et al.   EUROPEAN UROLOGY

Prostate cancer risk in men with prostate and breast cancer family history: results from the REDUCE study (R1)

(2011) J.-A. Thomas et al.   JOURNAL OF INTERNAL MEDICINE

GWAS SNP Replication among African American and European American men in the North Carolina-Louisiana prostate cancer project (PCaP)

(2010) Zongli Xu et al.   PROSTATE

Inherited genetic markers discovered to date are able to identify a significant number of men at considerably elevated risk for prostate cancer

(2010) Jielin Sun et al.   PROSTATE

Estimation of absolute risk for prostate cancer using genetic markers and family history

(2009) Jianfeng Xu et al.   PROSTATE

Multiple Novel Prostate Cancer Predisposition Loci Confirmed by an International Study: The PRACTICAL Consortium

(2008) Z. Kote-Jarai et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Cumulative Association of Five Genetic Variants with Prostate Cancer

(2008) S. Lilly Zheng et al.   NEW ENGLAND JOURNAL OF MEDICINE

Polygenes, Risk Prediction, and Targeted Prevention of Breast Cancer

(2008) Paul D.P. Pharoah et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clinical utility of five genetic variants for predicting prostate cancer risk and mortality

(2008) Claudia A. Salinas et al.   PROSTATE